![The pipeline and market for psoriasis drugs](https://buywhatyoulove.online/wp-content/uploads/2024/02/d41573-024-00018-2_26665626-770x302.jpg)
The pipeline and market for psoriasis drugs
Psoriasis is a chronic T-lymphocyte-mediated inflammatory disorder that affects 2–3% of the population globally. It is associated with abnormal keratinocyte proliferation, and is clinically characterized by erythematous, clearly demarcated papules and rounded plaques. Approximately 75% of patients with psoriasis will have at least one comorbid condition, with psoriatic arthritis being the most common.
Competing Interests
The authors declare no competing interests.